Hi Waynesworld and George1972
We all know that your Contribution on this thread re Science is great..
JG stated in PER asx announcement that DMD could generate $1 billion per annum..So let’s take out costs =
so we arrive @ $500 million per annum
X eps biotechs work on multiples of 15 to over 100
Eg Sarepta
I’m my opinion the bigger game for PER is the inflammation market
I mentioned in my previous post that only getting 10% of the inflammation market would earn us $10 billion per annum
So guys
Do you agree that the inflammation market will be our primary focus and big $$ earner ?
Hi Waynesworld and George1972We all know that your Contribution...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.004(4.35%) |
Mkt cap ! $79.33M | |||
| Open | High | Low | Value | Volume |
| 9.1¢ | 9.2¢ | 8.7¢ | $87.86K | 983.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61583 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 16883 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.8¢ |
Change
-0.004 ( 2.76 %) |
||||
| Open | High | Low | Volume | ||
| 9.1¢ | 9.1¢ | 8.7¢ | 237651 | ||
| Last updated 15.58pm 17/06/2024 ? | |||||
| PER (ASX) Chart |
